Cargando…

Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy

Hematological malignancies are important diseases that need more powerful therapeutics. Even with current targeting therapies, such as rituximab and other chemotherapeutic agents, there is a need to develop new treatment strategies. Combination therapy seems the best option to target the tumor cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Shammari, Ahmed Majeed, Rameez, Huda, Al-Taee, Maha F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996254/ https://www.ncbi.nlm.nih.gov/pubmed/27579294 http://dx.doi.org/10.2147/OV.S95250

Ejemplares similares

Caspase Dependent and Independent Anti-hematological Malignancy Activity of AMHA1 Attenuated Newcastle Disease Virus
por: Mohammed, Mohammed S., et al.
Publicado: (2019)

Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo
por: Akram, Sura, et al.
Publicado: (2023)

Glucose Deprivation Induced by Acarbose and Oncolytic Newcastle Disease Virus Promote Metabolic Oxidative Stress and Cell Death in a Breast Cancer Model
por: Obaid, Qayssar A., et al.
Publicado: (2022)

Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells
por: Al-Ziaydi, Ahmed Ghdhban, et al.
Publicado: (2020)

3-Dimensional coculture of breast cancer cell lines with adipose tissue–Derived stem cells reveals the efficiency of oncolytic Newcastle disease virus infection via labeling technology
por: Salman, Marwa Ibrahim, et al.
Publicado: (2022)

2-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2019)

Clinical, molecular and cytopathological characterization of a Newcastle disease virus from an outbreak in Baghdad, Iraq
por: Al‐Shammari, Ahmed M., et al.
Publicado: (2020)

In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells
por: Al-Shammari, Ahmed M., et al.
Publicado: (2016)

Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy
por: Kadhim, Zahraa A., et al.
Publicado: (2022)

Infections in patients taking Rituximab for hematologic malignancies: two-year cohort study
por: Lanini, Simone, et al.
Publicado: (2013)

Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection
por: Vegivinti, Charan Thej Reddy, et al.
Publicado: (2022)

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
por: Salles, Gilles, et al.
Publicado: (2017)

Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab
por: Cattaneo, C., et al.
Publicado: (2021)

The Elevation of Cardio-Ankle Vascular Index in a Patient With Malignant Lymphoma Treated With a Combination Therapy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone
por: Shimizu, Naomi, et al.
Publicado: (2017)

Biologicals and Biosimilars in Hematology: The Case of Rituximab
por: Vulto, Arnold G.
Publicado: (2019)

Gossypiboma Masquerading as Small Bowel Malignancy
por: Boghratian, Amir H, et al.
Publicado: (2020)

Use of low-power He-Ne laser therapy to accelerate regeneration processes of injured sciatic nerve in rabbit
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2019)

Live attenuated measles virus vaccine therapy for locally established malignant glioblastoma tumor cells
por: Al-Shammari, Ahmed M, et al.
Publicado: (2014)

Impact of cluster of differentiation 20 expression and rituximab therapy in classical Hodgkin lymphoma: Real world experience
por: Abuelgasim, Khadega A., et al.
Publicado: (2021)

Isolation of Bovine leukemia virus from cows with persistent lymphocytosis in Iraq
por: Khudhair, Yahia Ismail, et al.
Publicado: (2021)

Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical Development
por: Davies, Andrew, et al.
Publicado: (2017)

Serological and molecular detection of bovine leukemia virus in cattle in Iraq
por: Khudhair, Yahia Ismail, et al.
Publicado: (2016)

Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity
por: Ojha, Shreesh, et al.
Publicado: (2016)

Relapsing De Novo Membranous Nephropathy
por: Ali, Ala, et al.
Publicado: (2022)

Safety of switching between rituximab biosimilars in onco-hematology
por: Urru, Silvana A. M., et al.
Publicado: (2021)

Comparative study to evaluate the anti-viral efficacy of Glycyrrhiza glabra extract and ribavirin against the Newcastle disease virus
por: Omer, Muhammad Ovais, et al.
Publicado: (2014)

Editorial: Oncolytic virotherapy
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2023)

Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
por: Candelaria, Myrna, et al.
Publicado: (2021)

Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era
por: Ha, Hyerim, et al.
Publicado: (2016)

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
por: Buti, María, et al.
Publicado: (2017)

The Anti-Cytokine Storm Activity of Quercetin Zinc and Vitamin C Complex
por: Sahib, Hayder B., et al.
Publicado: (2022)

Clinical trials with anti-angiogenic agents in hematological malignancies
por: Medinger, Michael, et al.
Publicado: (2010)

Metformin - its anti-cancer effects in hematologic malignancies
por: Podhorecka, Monika
Publicado: (2021)

Reverse Genetics of Newcastle Disease Virus
por: Cardenas-Garcia, Stivalis, et al.
Publicado: (2017)

Review detection of Newcastle disease virus
por: Mao, Qian, et al.
Publicado: (2022)

Pathologic Mechanisms of the Newcastle Disease Virus
por: Zhang, Di, et al.
Publicado: (2023)

Immune Therapies for Hematologic Malignancies
por: Olnes, Matthew J.
Publicado: (2021)

The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience
por: Nissen, Johanna C, et al.
Publicado: (2014)

Fibrosing Alveolitis in Hematologic Malignancy Patients Undergoing Hematopoietic Cell Transplantation
por: Salman, Huda, et al.
Publicado: (2010)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7dpuf84ctoetlj495ue39qrvvr